Login / Signup

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.

Anne Wing-Mui LeeStewart Y TungWai Tong NgVictor LeeRoger K C NganHorace C W ChoiLucy L K ChanLillian L SiuAlice W Y NgTo Wai LeungHarry H Y YiuBrian O'SullivanRick Chappell
Published in: Cancer (2017)
Long-term results have confirmed that CRT can significantly improve OS without excessive late toxicities for patients with regionally advanced NPC. However, more potent therapy is needed for improving distant control, especially for patients with stage IVA/B disease. Cancer 2017;123:4147-4157. © 2017 American Cancer Society.
Keyphrases